Bill Text: NJ A3768 | 2022-2023 | Regular Session | Introduced
Bill Title: Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2022-05-02 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A3768 Detail]
Download: New_Jersey-2022-A3768-Introduced.html
Sponsored by:
Assemblywoman GABRIELA M. MOSQUERA
District 4 (Camden and Gloucester)
Assemblyman WILLIAM F. MOEN, JR.
District 5 (Camden and Gloucester)
SYNOPSIS
Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning health benefits coverage and continuous glucose monitoring systems and supplementing various parts of the statutory law.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. A hospital service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
c. This section shall apply to those hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium.
2. a. A medical service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74 (C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
c. This section shall apply to those medical service corporation contracts in which the medical service corporation has reserved the right to change the premium.
3. a. A health service corporation contract that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1985, c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
c. This section shall apply to those health service corporation contracts in which the health service corporation has reserved the right to change the premium.
4. a. An individual health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:26-1 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the policy.
c. This section shall apply to those individual health insurance policies in which the insurer has reserved the right to change the premium.
5. a. A group health insurance policy that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the policy.
c. This section shall apply to those group health insurance policies in which the insurer has reserved the right to change the premium.
6. a. An individual health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the plan.
c. This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium.
7. a. A small employer health benefits plan that provides hospital and medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the plan.
c. This section shall apply to those health benefits plans in which the carrier has reserved the right to change the premium.
8. a. A health maintenance organization contract for health care services that is delivered, issued, executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
c. This section shall apply to those contracts for health care services under which the health maintenance organization has reserved the right to change the schedule of charges for enrollee coverage.
9. a. The State Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
10. a. The School Employees' Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital and medical expense benefits shall provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
11. This act shall take effect on the first day of the seventh month next following enactment and shall apply to all health benefits plans that are delivered, issued, executed or renewed in this State, or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act.
STATEMENT
This bill requires health insurers (health, hospital, and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
